Results 81 to 90 of about 2,646 (181)

Seasonal influenza mRNA vaccine induces stronger innate and comparable or better adaptive responses than licensed inactivated vaccines. [PDF]

open access: yesNPJ Vaccines
Bermúdez-Méndez E   +10 more
europepmc   +1 more source

Immunogenic Properties and Safety of a Quadrivalent Inactivated Subunit Adjuvanted Influenza Vaccine in Adults Aged 18 to 85 Years at the End of the COVID-19 Pandemic in the 2022-2023 Season. [PDF]

open access: yesVaccines (Basel)
Kostinov MP   +16 more
europepmc   +1 more source

IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination. [PDF]

open access: yesEMBO Mol Med
Zhang W   +21 more
europepmc   +1 more source

The first outbreak of herpes gladiatorum in Thailand: an investigation of boxing gyms in Phuket, May-August 2022. [PDF]

open access: yesWestern Pac Surveill Response J
Srisaeng S   +6 more
europepmc   +1 more source

Genetic characterization and whole-genome sequencing-based genetic analysis of influenza B in Shandong Province during 2015-2024. [PDF]

open access: yesSci Rep
Wu J   +12 more
europepmc   +1 more source

Efficiency of Waste Management in Phuket Province

open access: yesResearch Journal of Business Management, 2014
Chiewcharn Sivakunako   +2 more
openaire   +1 more source

An mRNA influenza vaccine induces immunity comparable to an adjuvanted vaccine in a randomized trial. [PDF]

open access: yesNPJ Vaccines
Henry C   +12 more
europepmc   +1 more source

Blinatumomab limits humoral antibody response despite boosting the influenza vaccine schedule in children with B-ALL. [PDF]

open access: yesBlood Adv
Chiu SK   +10 more
europepmc   +1 more source

Pre-existing influenza antibodies, younger age, and increased CD4 T<sub>E+EM</sub> predict influenza vaccination responses in transplant recipients. [PDF]

open access: yesHum Immunol
Rollenhagen C   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy